PharmaEngine (ROCO:4162) Dividend Payout Ratio: 0.00 (As of Dec. 2025)


ROCO:4162 PharmaEngine Inc ROCO:4162
78 GF Score
Price NT$63.60
GF Value NT$115.32
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is PharmaEngine Dividend Payout Ratio?

PharmaEngine ROCO:4162 -0.31% 78 Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus rates ROCO:4162 with a GF Score™ of 78/100 and a GF Value™ of NT$115.32 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 133 Biotechnology companies, PharmaEngine ranks worse than 90.98% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. PharmaEngine's Dividend Payout Ratio for the months ended in Dec. 2025 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of PharmaEngine Inc is 2.23, which seems too high.

The historical rank and industry rank for PharmaEngine's Dividend Payout Ratio or its related term are showing as below:

ROCO:4162' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.12   Med: 0.96   Max: 3.45
Current: 2.23

During the past 13 years, the highest Dividend Payout Ratio of PharmaEngine was 3.45. The lowest was 0.12. And the median was 0.96.

ROCO:4162's Dividend Payout Ratio is ranked worse than
90.98% of 133 companies
in the Biotechnology industry
Industry Median: 0.44 vs ROCO:4162: 2.23

As of today (2026-07-09), the Dividend Yield % of PharmaEngine is 9.40%.

During the past 13 years, the highest Trailing Annual Dividend Yield of PharmaEngine was 11.19%. The lowest was 0.55%. And the median was 1.84%.

PharmaEngine's Dividends per Share for the months ended in Dec. 2025 was NT$0.00.

During the past 12 months, PharmaEngine's average Dividends Per Share Growth Rate was 300.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 30.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 35.20% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 13.50% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of PharmaEngine was 58.70% per year. The lowest was -33.00% per year. And the median was 19.35% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

PharmaEngine (ROCO:4162) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

PharmaEngine Dividend Payout Ratio Related Terms

PharmaEngine Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for PharmaEngine's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEngine Dividend Payout Ratio Chart

PharmaEngine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.86 1.22 1.05 0.12 2.23

PharmaEngine Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 6.32 0.00

ROCO:4162 vs VRTX, REGN, ALNY: Dividend Payout Ratio Comparison

For the Biotechnology subindustry, PharmaEngine's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaEngine Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaEngine's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where PharmaEngine's Dividend Payout Ratio falls into.


ROCO:4162
78GF Score
PharmaEngine Inc ROCO:4162
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaEngine Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

PharmaEngine's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=6/ 2.69
=2.23

PharmaEngine's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0/ 0.91
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
PharmaEngine (ROCO:4162) has a Dividend Payout Ratio of 0.00 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on PharmaEngine and its competitors. Over the past decade, PharmaEngine's Dividend Payout Ratio has ranged from 0.12 to 3.45. According to the industry distribution chart, PharmaEngine ranks #121 out of 133 companies in the Biotechnology industry, placing it in the top 91%.
Is PharmaEngine's Dividend Payout Ratio too high?
PharmaEngine's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 3.45. Based on the distribution chart, PharmaEngine ranks #121 out of 133 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PharmaEngine has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PharmaEngine's Dividend Payout Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PharmaEngine ranks #121 out of 133 companies for Dividend Payout Ratio. This places PharmaEngine in the lower half of its industry. The industry median Dividend Payout Ratio is 0.44. Historically, PharmaEngine's own Dividend Payout Ratio has ranged from 0.12 to 3.45 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.44, based on 133 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on PharmaEngine and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaEngine's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEngine stock overvalued right now?
Based on GuruFocus' analysis, PharmaEngine (ROCO:4162) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$115.32, compared to a current price of NT$63.60 — trading 44.8% below its estimated fair value. The current Dividend Payout Ratio is 0.00. PharmaEngine's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For PharmaEngine (ROCO:4162), the current Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PharmaEngine (ROCO:4162) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEngine stock appears to be undervalued. The current stock price of NT$63.60 is trading 44.8% below its estimated GF Value™ of NT$115.32. GuruFocus considers PharmaEngine to be Significantly Undervalued.

Key valuation signals for ROCO:4162:

  • Dividend Payout Ratio: 0.00
  • GF Value™: NT$115.32 vs. price of NT$63.60 (44.8% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4162 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PharmaEngine Business Description

Address No. 10, Minsheng East Road, 11th Floor, Section 3, Taipei, TWN, 104
PharmaEngine Inc is a biopharmaceutical company engaged in the development of new drugs and therapeutic drugs for cancer. It is a specialty pharma company that adopts the no research, development-only model and the networked pharma model for new drug development. Its key products and pipeline projects include ONIVYDE, a treatment for metastatic pancreatic cancer approved in multiple markets, as well as oncology candidates such as PEP07 and PEP08. It generates revenue from the sales of goods.
78GF Score

Get the complete analysis for ROCO:4162

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$63.60
Price
NT$115.32
GF Value